O
Otto M. Hess
Researcher at University of Bern
Publications - 264
Citations - 18661
Otto M. Hess is an academic researcher from University of Bern. The author has contributed to research in topics: Diastole & Coronary artery disease. The author has an hindex of 68, co-authored 264 publications receiving 18118 citations. Previous affiliations of Otto M. Hess include University of Düsseldorf & University of Naples Federico II.
Papers
More filters
Journal ArticleDOI
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study
Joost Daemen,Peter Wenaweser,Keiichi Tsuchida,Linda Abrecht,Sophia Vaina,Cyrill Morger,Neville Kukreja,Peter Jüni,Georgios Sianos,Gerrit Hellige,Ron T. van Domburg,Otto M. Hess,Eric Boersma,Bernhard Meier,Stephan Windecker,Patrick W. Serruys +15 more
TL;DR: Late stent thrombosis was encountered steadily with no evidence of diminution up to 3 years of follow-up, and Acute coronary syndrome at presentation and diabetes were independent predictors of stentThromBosis.
Journal ArticleDOI
Incomplete Stent Apposition and Very Late Stent Thrombosis After Drug-Eluting Stent Implantation
Stéphane Cook,Peter Wenaweser,Mario Togni,Michael Billinger,Cyrill Morger,Christian Seiler,Rolf Vogel,Otto M. Hess,Bernhard Meier,Stephan Windecker +9 more
TL;DR: Incomplete stent apposition is highly prevalent in patients with very late stent thrombosis after DES implantation, suggesting a role in the pathogenesis of this adverse event.
Journal ArticleDOI
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
Stephan Windecker,Andrea Remondino,Franz R. Eberli,Peter Jüni,Lorenz Räber,Peter Wenaweser,Mario Togni,Michael Billinger,David Tüller,Christian Seiler,Marco Roffi,Roberto Corti,Gabor Sütsch,Willibald Maier,Thomas F. Lüscher,Otto M. Hess,Matthias Egger,Bernhard Meier +17 more
TL;DR: As compared with paclitaxel-eluting stents, the use of sirolimus-eluted stents results in fewer major adverse cardiac events, primarily by decreasing the rates of clinical and angiographic restenosis.
Journal ArticleDOI
Outcome of Pulmonary Vascular Disease in Pregnancy: A Systematic Overview From 1978 Through 1996
TL;DR: In the last two decades maternal mortality was comparable in patients with Eisenmenger's syndrome and PPH; however, it was relevantly higher in SVPH.
Journal ArticleDOI
Decreased Rate of Coronary Restenosis after Lowering of Plasma Homocysteine Levels
G. Schnyder,Marco Roffi,Riccardo Pin,Yvonne Flammer,Helmut W. Lange,Franz R. Eberli,Bernhard Meier,Zoltan G. Turi,Otto M. Hess +8 more
TL;DR: Treatment with a combination of folic acid, vitamin B12, and pyridoxine significantly reduces homocysteine levels and decreases the rate of restenosis and the need for revascularization of the target lesion after coronary angioplasty.